Differential cadherin expression: potential markers for epithelial to mesenchymal transformation during tumor progression.
about
Role of nuclear receptors in breast cancer stem cellsPRC2/EED-EZH2 complex is up-regulated in breast cancer lymph node metastasis compared to primary tumor and correlates with tumor proliferation in situN-cadherin regulates spatially polarized signals through distinct p120ctn and β-catenin-dependent signalling pathways.Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast.Proline-rich tyrosine kinase 2 (Pyk2) promotes cell motility of hepatocellular carcinoma through induction of epithelial to mesenchymal transition"A novel in vivo model for the study of human breast cancer metastasis using primary breast tumor-initiating cells from patient biopsies".Unmasking epithelial-mesenchymal transition in a breast cancer primary culture: a study reportCirculating tumor cells as a window on metastasis biology in lung cancer.Functional heterogeneity of osteopontin isoforms in non-small cell lung cancer.Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and xenografted human breast cancer cellsN-cadherin regulates mammary tumor cell migration through Akt3 suppression.Expression of E-cadherin, N-cadherin and snail and their correlation with clinicopathological variants: an immunohistochemical study of 132 invasive ductal breast carcinomas in Egypt.Loss of retinal cadherin facilitates mammary tumor progression and metastasis.Curcumin inhibits breast cancer stem cell migration by amplifying the E-cadherin/β-catenin negative feedback loopDichotomy effects of Akt signaling in breast cancer.Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion frontThe pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.Noncanonical TGF-β signaling during mammary tumorigenesis.The relevance of the TGF-β Paradox to EMT-MET programsMolecular mechanisms controlling E-cadherin expression in breast cancer.Cytokeratin-based CTC counting unrelated to clinical follow upPrevention of mammary carcinogenesis in MMTV-neu mice by cruciferous vegetable constituent benzyl isothiocyanate.Restricted expression of classic cadherins in the spinal cord of the chicken embryo.Cadherins Associate with Distinct Stem Cell-Related Transcription Factors to Coordinate the Maintenance of Stemness in Triple-Negative Breast Cancer.Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasisImaging pH and metastasis.Review: Cell Dynamics in Malignant Pleural Effusions.E-cadherin plasticity in prostate cancer stem cell invasionMiRNAs-mediated cisplatin resistance in breast cancer.FRK inhibits migration and invasion of human glioma cells by promoting N-cadherin/β-catenin complex formation.BRCA1 and p53 regulate critical prostate cancer pathways.The RhoA pathway mediates MMP-2 and MMP-9-independent invasive behavior in a triple-negative breast cancer cell line.N-cadherin expression level as a critical indicator of invasion in non-epithelial tumorsPleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma.PTTG induces EMT through integrin αVβ3-focal adhesion kinase signaling in lung cancer cells.Gene silencing for epidermal growth factor receptor variant III induces cell-specific cytotoxicityAnalysis of Contractility and Invasion Potential of Two Canine Mammary Tumor Cell Lines.Quercetin inhibits epithelial-mesenchymal transition, decreases invasiveness and metastasis, and reverses IL-6 induced epithelial-mesenchymal transition, expression of MMP by inhibiting STAT3 signaling in pancreatic cancer cells.Cat Mammary Tumors: Genetic Models for the Human Counterpart.EMT markers in lung adenocarcinoma pleural effusion spheroid cells.
P2860
Q26750359-E6927740-DBCC-4E68-894F-8240FD2A59D7Q28484272-137C1460-26C7-4DE1-A2BC-F719917B61E6Q30418563-22CC2624-875D-4C8B-9C57-46094071E6ACQ33502878-B5CB4AAA-C9C0-43FB-8004-521AB74727E8Q33886179-AF1025F5-2F8E-42D4-914A-A16A822B3EB4Q34122934-956E6037-EAF1-452D-B4F8-4CEE07758A4BQ34324979-8072BE91-6B40-422C-B97A-4D89902B2140Q34756160-3D498500-21C8-4504-B517-BA0CBF657FB4Q35065341-C96015CF-B590-47A1-9921-83D3773E20B3Q35091219-DDF39D09-C78A-40EE-BE95-BEB016CE2B31Q35153665-A45DA375-E23D-421E-BCE6-C1623F52ADF2Q35232419-01224190-48BE-4E5D-A9AE-8F7C3AA12443Q35244952-1AF40519-24D8-4D6A-BC10-EC7E5A1B4937Q35654152-F3AF23B6-DE83-4AAF-946F-43219D80B698Q36388391-E1564A64-234F-44F1-B3A2-A9D032F1A261Q36848899-ACBEE884-E52F-4C32-8AFD-1F4ACF317E1FQ37040558-DF3B00AC-EA56-43E1-92F3-93604DD0C1E8Q37044600-9F1004F1-63FB-41C2-8980-D247284DFA1DQ37118399-AC61C0B1-8380-4EB3-91E0-F53BA4673266Q37238311-B40375C5-51DA-4F24-AC4E-C8F9D3E4075AQ37274573-8C1D22C3-1B17-4017-8421-19C97D16F5EFQ37480364-B71AB526-65B6-40CD-B605-4648F65D0425Q37689535-80F2246E-D6E9-4E7D-98F8-A3BC71819B9CQ37723691-9D45AA0A-0E2F-45B3-8C57-E24D435E384CQ37730957-D12376A3-26D3-4519-9170-A580B6B2A6B8Q37851075-4DC4248A-D98F-4A2F-B76B-18BC897BB9E3Q38247899-8FB368D0-B90B-4DCE-AF8F-7D4E8FC51FE9Q38561949-DEB9963F-8A36-422C-8ACA-B1A271A70F80Q38905681-14D13B59-EFE9-4BE0-95F8-39035E21D7D3Q38980862-21FE1506-5284-4DB8-8284-D6EE245B2521Q39152560-81BC035A-F79A-4B8A-8373-78849310FD85Q39223186-A0935A15-E115-4998-8CAC-E65F4F5061E6Q39277676-717CDFC2-5E63-4AA8-933B-27FFB72B1EDAQ39382947-A2D73ACA-C0DE-4CE6-BDB4-89FF037B082AQ39443523-BB425479-057E-4225-A1DF-A9020D5894F5Q39918802-EBA0F830-7E05-4B81-A786-873382BBF7ADQ41684904-5A369465-9936-4AA2-9CE9-7A26A63E77D2Q42283186-BCB97F26-DA0E-4A38-A444-B127AC247839Q43378663-FF8E5561-58CF-4410-9273-1587BD6F7782Q46094278-17871718-5CEC-45A8-ADFE-4B661EA21EAD
P2860
Differential cadherin expression: potential markers for epithelial to mesenchymal transformation during tumor progression.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Differential cadherin expressi ...... tion during tumor progression.
@en
type
label
Differential cadherin expressi ...... tion during tumor progression.
@en
prefLabel
Differential cadherin expressi ...... tion during tumor progression.
@en
P2093
P2860
P1476
Differential cadherin expressi ...... tion during tumor progression.
@en
P2093
Georgia Agiostratidou
Greg R Phillips
James Hulit
Rachel B Hazan
P2860
P2888
P304
P356
10.1007/S10911-007-9044-6
P577
2007-09-01T00:00:00Z